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Abstract
Background: To estimate the prevalence of diagnosed and undiagnosed diabetes mellitus,
impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and combined IFG/IGT in a large
urban Iranian population aged ≥ 20 years.
Methods: The study population included 9,489 participants of the Tehran Lipid and Glucose Study
with full relevant clinical data. Age-standardized prevalence of diabetes and glucose intolerance
categories were reported according to the 2003 American Diabetes Association definitions. Age-
adjusted logistic regression models were used to estimate the numbers needed to screen (NNTS)
to find one person with undiagnosed diabetes.
Results: The prevalence of diagnosed and undiagnosed diabetes, isolated IFG, isolated IGT, and
combined IFG/IGT were 8.1%, 5.1%, 8.7%, 5.4% and 4.0% in men and 10%, 4.7%, 6.3%, 7.6%, and
4.5% in women respectively. Participants with undiagnosed diabetes had higher age, body mass
index (BMI), waist circumference, systolic and diastolic blood pressures, triglycerides (all p values
<0.001) and lower HDL-cholesterol (only in women, p < 0.01) compared to normoglycemic
subjects. Undiagnosed diabetes was associated with family history of diabetes, increased BMI (≥ 25
kg/m2), abdominal obesity, hypertriglyceridemia, hypertension and low HDL-cholesterol levels.
Among men, a combination of increased BMI, hypertension, and family history of diabetes led to a
NNTS of 1.6 (95% CI: 1.57–1.71) and among women a combination of family history of diabetes
and abdominal obesity, yielded a NNTS of 2.2 (95% CI: 2.1–2.4).
Conclusion: In conclusion, about one third of Tehranian adults had disturbed glucose tolerance
or diabetes. One- third of total cases with diabetes were undiagnosed. Screening individuals with
BMI ≥ 25 kg/m2 (men), hypertension (men), abdominal obesity (women) and family history of
diabetes may be more efficient.
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The number of people with type 2 diabetes mellitus is
increasing worldwide [1] and many of these individuals
remain unidentified [2]. Undiagnosed type 2 diabetes and
impaired glucose regulation are reported to have substan-
tial clinical importance [3,4] and increase the risk of car-
diovascular morbidity and mortality [5,6]. Undiagnosed
diabetes may also impose substantial public health impli-
cations because these subjects remain untreated and at
risk for complications [2]. Although screening for undiag-
nosed diabetes within general practice by measuring fast-
ing blood glucose is feasible but it would be best targeted
at individuals with multiple risk factors for diabetes [7].
Since limited data are available on the Iranian population
regarding prevalence of diabetes and other glucose toler-
ance abnormalities [8,9], this study aimed to determine
the age and gender-specific prevalence of undiagnosed
and diagnosed diabetes, impaired fasting glucose (IFG),
impaired glucose tolerance (IGT), and combined IFG/IGT
in a large urban population of Iranian adults in Tehran.
We also assessed, the number needed to screen (NNTS), to
identify one person with undiagnosed diabetes, and char-
acteristics of individuals that might be most effectively tar-




The Tehran Lipid and Glucose Study (TLGS) is a longitu-
dinal study, conducted to determine the risk factors for
non-communicable diseases among the Tehranian popu-
lation [10]. Briefly, 15,005 people aged 3 years and over,
living in district 13 of Tehran, representative of the capital
city, were selected by multistage cluster random sampling
methods in the cross-sectional phase 1 of the TLGS from
1999 to 2001. The ethical committee of the research insti-
tute for endocrine sciences of Shahid Beheshti University
(M.C) approved design of the study and informed written
consent was obtained from participants older than 15
years, and from their parents if they were younger. In this
study, we included participants aged ≥ 20 years (n =
10,368), if they did not report having diabetes according
to a physician diagnosis and were not currently taking
insulin or oral anti-diabetic agents (diagnosed diabetes);
also individuals were excluded from the analysis if they
had a missing fasting (n = 290) or 2-hours glucose value
(n = 589) Finally, 9,489 individuals (men to women ratio
4,006:5,483), aged ≥ 20 years with valid data on glucose
tolerance, were included in the current data analysis. The
overall response rate was 91.5%. Demographic informa-
tion was obtained by use of a standard and pretested ques-
tionnaire. Subjects were questioned about past and family
(parents and siblings) history of diabetes mellitus and or
taking of any anti-diabetic drugs.
Measurement of Clinical variables
A detailed description of the methods for measuring
anthropometric variables including weight, height and
waist circumference (WC) has been previously reported
[10]. Body mass index (BMI) was calculated as weight in
kilograms divided by the height in meters squared. Blood
pressure was measured twice in a sitting position after 15
minutes rest and the mean of the two measurements was
considered as the participant's blood pressure.
Laboratory measurements
After all participants had fasted for 12–14 hours over-
night, blood samples were drawn between 7:00 to 9:00
and centrifuged within 30–45 min of collection. A Sellec-
tra 2 auto-analyzer (Vital Scientific, Spankeren, Nether-
lands) was used in the TLGS research laboratory. Fasting
plasma glucose (FPG) was measured by enzymatic colori-
metric method with glucose oxidase technique. For 2h-
OGTT, 75 g glucose was administrated orally and plasma
glucose was measured 2 hours later (2h-PG). For serum
lipid measurements, total cholesterol and triglycerides
(TGs) kits (Pars Azmoon Inc., Iran) were used. Using
enzymatic colorimetric tests, we assayed TGs with glycerol
phosphate oxidase. High-density lipoprotein cholesterol
(HDL-C) was measured after precipitation of the lipopro-
tein B containing lipoproteins with phosphotungstic acid.
Inter- and intra- assay coefficients of variation (CV) for
fasting and 2-hour glucose were 2.2%. Inter- and intra-
assay CVs were 2% and 0.5% for HDL-C and 1.6% and
0.6% for TGs, respectively.
Definition of terms
Low leisure time physical activity was defined as exercis-
ing less than three times per week. Increased BMI was
defined as ≥ 25 kg/m2, hypertension as systolic blood
pressure ≥ 140 and/or diastolic blood pressure ≥ 90
mmHg, hypertriglyceridemia as TGs > 2.8 mmol/l and
low HDL-C levels as HDL-C< 0.9 mmol/l [11]. Abdomi-
nal obesity was defined as waist circumference >102
(men) and > 88 cm (women) [12]. According to the 2003
ADA diagnostic criteria, people without previously diag-
nosed diabetes were categorized as follows: Normal glu-
cose tolerance (NGT), FPG < 5.6 and 2h-PG <7.7 mmol/l;
undiagnosed diabetes, FPG ≥ 7.0 or 2h-PG ≥ 11.1 mmol/
l; isolated impaired fasting glucose (IFG), FPG 5.6 to 6.9
and 2h-PG <7.7 mmol/l; isolated impaired glucose toler-
ance (IGT), 2h-PG 7.7 to 11.0 and FPG <5.6 mmol/l; and
combined IFG and IGT (IFG/IGT) as FPG 5.6 to 6.9 and
2h-PG 7.7 to 11.0 mmol/l [13].
Statistical analyses
Separate analyses were carried out for each gender. Taking
into account the multistage stratified cluster random sam-
pling procedure, total and gender-specific prevalence
(95% confidence intervals) of diagnosed and undiag-Page 2 of 7
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lence of IFG, IGT and IFG/IGT were calculated. Sampling
weights, which accounted for the unequal probabilities of
selection resulting from the complex design and non-
response adjustment factors based on Iranian census
bureau data (1996) on age and gender, were incorporated
to the estimation process. Age-and gender-specific crude
prevalence were also directly standardized to the overall
age distribution in the world population [14]. Differences
between age and gender groups were tested using the Chi-
Square test. Means (standard errors of mean) are pre-
sented for HDL-C values, anthropometric parameters and
systolic and diastolic blood pressure. Values for TGs were
log-transformed because of skewed distribution. Analysis
of Covariance (ANCOVA) was used to assess significance
of difference between normal individual (NGT) and indi-
viduals of 5 different glucose tolerance categories consid-
ering age as a covariate. Adjustment for multiple
comparisons was done by the Bonferroni test. Controlling
for age, we used logistic regression to determine the
impact of potential risk factors on undiagnosed diabetes.
In the multivariate model, all of the associated risk factors
from age-adjusted analysis were included. Predictive mar-
ginals computed by logistic regression were used to esti-
mate prevalence of undiagnosed diabetes in each risk
factor group. NNTS, to identify one person with undiag-
nosed diabetes, was obtained as the inverse of the esti-
mated prevalence of undiagnosed diabetes in each
(univariate) and a cluster (multivariate) of risk groups
[15]. Statistical significance was set at p < 0.05 and all val-
ues were two-sided. Statistical analysis was performed by
the Statistical Package for Social Sciences, version 15.0 for
windows (SPSS Inc., Chicago, IL).
Results
A total of 9,489 subjects (men: 4,006, women: 5,483),
mean age of 43.5 ± 14.5 years, were included in the cur-
rent data analysis. Diagnosed diabetes was detected in
9.1% of individuals (n = 877), half of which (n = 438)
were on anti-diabetic drugs, while the other half (n = 439)
were not. Undiagnosed diabetes, isolated IFG, isolated
IGT, and combined IFG/IGT were identified in 4.9%,
7.3%, 6.7%, and 4.2% of individuals respectively. Age-
standardized estimated prevalence of various glucose tol-
erance categories was comparable to the crude sample-
based prevalence (Table 1).
Gender difference in prevalence of glucose abnormalities
The prevalence of undiagnosed diabetes as well as com-
bined IFG/IGT did not differ by gender; IFG was more
prevalent among men than women, (8.7% vs. 6.3%
respectively, p < 0.001), whereas IGT was more prevalent
among women than men (7.6% vs. 5.4% respectively, p <
0.001), (Table 1). The prevalence of diagnosed diabetes
Table 1: Age and gender wise prevalence of different glucose intolerance categories among Tehranian adults.
Age group (years) Study Population (n) Isolated IFG (%) Isolated IGT (%) IFG/IGT (%) Undiagnosed Diabetes (%) Known Diabetes (%)
Men
20–29 694 5.1 1.0 0.7 0.8 1.1
30–39 1054 9.8 4.4 1.7 1.6 2.8
40–49 775 11.1 6.9 4.6 5.2 6.9
50–59 605 11.2 7.0 7.3 9.3 14.7
60–69 637 8.5 8.2 9.4 8.6 20.3
≥ 70 241 7.1 11.7 6.2 14.9 19.1
Un-standardized 4006 9.1(8.2–10.0) 5.8 (5.1–6.5) 4.6 (4.0–5.2) 5.1 (4.4–5.8) 9.0 (8.1–9.9)
Age-standardizeda 4006 8.7 (7.8–9.6) 5.4 (4.7–6.1) 4.0 (3.4–4.6) 5.1 (4.4–5.8) 8.1 (7.3–8.9)
Women
20–29 1171 3.4 2.7 0.9 0.4 0.7
30–39 1464 5.4 6.9 2.6 2.1 3.0
40–49 1131 7.8 9.7 6.0 6.9 8.7
50–59 926 9.4 9.9 7.3 8.4 17.5
60–69 664 9.1 9.6 7.6 9.8 25.4
≥ 70 127 4.9 12.5 7.4 6.1 27.2
Un-standardized 5483 6.6 (5.9–7.3) 7.6 (6.9–8.3) 4.6 (4.0–5.2) 4.9 (4.3–5.5) 9.4 (8.6–10.2)
Age-standardizeda 5483 6.3 (5.7–6.9) 7.6 (6.9–8.3) 4.5 (4.0–5.0) 4.7 (4.1–5.3) 10 (9.2–10.8)
Total (95%CI)
Un-standardized 9489 7.7 (7.2–8.2) 6.8 (6.3–7.3) 4.6 (4.2–5.0) 5.0 (4.6–5.4) 9.2 (8.6–9.8)
Age-standardizeda 9489 7.3 (6.8–7.8) 6.7 (6.2–7.2) 4.2 (3.8–4.6) 4.9 (4.5–5.3) 9.1 (8.5–9.7)
IFG: impaired fasting glucose, IFG/IGT: combined impaired fasting glucose and impaired glucose tolerance, IGT: impaired glucose tolerance, NGT: 
normal glucose tolerance.
a: age-standardization is based on world population 2000.Page 3 of 7
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0.0015). No significant difference was observed in the
total prevalence of diabetes (diagnosed and undiagnosed)
between men and women (13.2 vs. 14.7%, P = 0.3).
Age- and gender- specific prevalence of glucose abnormalities 
(standardized to the world population 2000)
The age-specific prevalence of diagnosed diabetes rose
with age, up to the 7th and 8th decade of life in men and
women respectively. The age-specific prevalence of undi-
agnosed diabetes rose with age in both genders (p for
trends < 0.001); but there was some decrease in men aged
60 to 69 years and women aged ≥ 70 years. The prevalence
of combined IFG/IGT increased with age up to 7th decade
in both genders (p for trends < 0.001). Consistent
increases in prevalence of IGT with age were also observed
in both genders (p for trends < 0.001). Prevalence of IFG
increased with age among women (p for trends <0.001)
but not men (p for trends = 0.15) (Table 1). Among men,
the proportion of undiagnosed diabetes relative to total
diabetes remained the same (40%) up to the 8th decade of
life, when it increased to 70%. Among women, however,
this proportion was the same as those observed among
men up to the 6th decade of life, when it began to decrease
to 30% and 20% in the 7th and 8th decades of life respec-
tively.
Cardiovascular risk factors and glucose tolerance
In both genders all cardiovascular risk factors (except for
HDL-cholesterol) were higher among subjects with any
glucose abnormality as compared to NGT (Table 2).
Among men, age-adjusted mean HDL-C level did not
change by glucose tolerance groups, while women sub-
jects with diabetes (diagnosed and undiagnosed) and
IFG/IGT had lower HDL-C levels than normoglycaemic
subjects. Overall, undiagnosed diabetes cases had higher
cardiovascular disease risk profiles than diagnosed dia-
betic subjects, with subjects with IFG, IGT and IFG/IGT
falling somewhere between undiagnosed diabetic and
normoglycaemic participants.
Number needed to screen (NNTS) for undiagnosed diabetes
In the age-adjusted analysis, undiagnosed diabetes was
associated with family history of diabetes, increased BMI,
abdominal obesity, hypertriglyceridemia and hyperten-
sion in both genders and with low HDL-C levels only in
women (Table 3). Increased BMI (OR; 95%CI: 4.1; 2.7–
6.1) and abdominal obesity (2.9; 2.1–4.1) had the highest
association with undiagnosed diabetes among men and
women respectively. In multivariate analysis, increased
BMI (3.3; 2.2–5.0), hypertension (2.2; 1.6–3.0), hyper-
triglyceridemia (2.3; 1.6–3.1) and family history of diabe-
tes (2.1; 1.5–2.9) were associated with undiagnosed
diabetes in men. The corresponding variables in women
were abdominal obesity (2.5; 1.8–3.6), hypertriglyceri-
demia (2.6; 1.9–3.6) and family history of diabetes (2.0;
1.4–2.7).
NNTS (95%CI) to identify one person with un-diagnosed
diabetes in each risk factor groups is presented in Table 4.
The lowest NNTS in men and women was observed for
subjects with abdominal obesity and hypertriglyceridemia
Table 2: Anthropometric and metabolic characteristics of participants by glucose tolerance categories.a
Variables NGT/NFG Isolated IFG Isolated IGT Combined IFG/IGT Undiagnosed diabetes Known diabetes
Men
Age (years) 38.4 ± 1.01 43.7 ± 1.02† 50.4 ± 1.02† 53.7 ± 1.02† 54.2 ± 1.02† 56.1 ± 1.02†
BMI (kg/m2) 25.3 ± 0.1 26.3 ± 0.2† 27.0 ± 0.3† 27.4 ± 0.3† 28.0 ± 0.3† 26.6 ± 0.2†
WC (cm) 87.1 ± 0.2 90.0 ± 0.6† 91.7 ± 0.7† 93.1 ± 0.8† 94.4 ± 0.8† 91.0 ± 0.6†
SBP (mmHg) 119 ± 0.3 121 ± 0.9 125 ± 1.1† 128 ± 1.2† 131 ± 1.2† 126 ± 0.9†
DBP (mmHg) 76.9 ± 0.2 79.1 ± 0.6* 79.8 ± 0.7† 81.0 ± 0.8† 81.3 ± 0.8† 79.3 ± 0.6*
HDL-C (mmol/l) 1.0 ± 0.01 0.97 ± 0.01 0.99 ± 0.01 1.01 ± 0.01 0.98 ± 0.01 0.97 ± 0.01
TGs (mmmol/l) 1.61 ± 0.01 1.86 ± 0.01† 2.0 ± 0.01† 2.02 ± 0.01† 2.38 ± 0.01† 2.08 ± 0.01†
Women
Age (year) 36.4 ± 1.01 44.7 ± 1.01† 45.4 ± 1.02† 48.8 ± 1.02† 51.1 ± 1.02† 54.0 ± 1.01†
BMI (kg/m2) 27.1 ± 0.1 28.8 ± 0.2† 28.3 ± 0.2† 29.4 ± 0.3† 29.4 ± 0.3† 27.7 ± 0.2
WC (cm) 86.2 ± 0.2 91.1 ± 0.6† 89.5 ± 0.5† 92 ± 0.7† 94.1 ± 0.7† 90.4 ± 0.5†
SBP (mmHg) 117 ± 0.3 121 ± 0.9* 122 ± 0.8† 126 ± 1.0† 128 ± 1.0 † 127 ± 0.8†
DBP (mmHg) 76.9 ± 0.2 79.3 ± 0.5† 80.4 ± 0.5† 80.5 ± 0.6† 82.1 ± 0.6† 79.7 ± 0.5†
HDL-C (mmHg) 1.18 ± 0.01 1.14 ± 0.01 1.14 ± 0.01 1.10 ± 0.01* 1.11 ± 0.01* 1.12 ± 0.01*
TGs (mmol/l) 1.43 ± 0.01 1.60 ± 0.01† 1.77 ± 0.01† 1.84 ± 0.01† 2.16 ± 0.01† 1.90 ± 0.01†
a: According to the 2003 ADA classification.
Data are means ± SEM (geometric mean ± SE for triglycerides).* p < 0.01, † p < 0.001: age-adjusted (except for age) comparison with combined 
normal glucose tolerance and normal fasting glucose (NGT/NFG). BMI: body mass index, DBP: diastolic blood pressure, HDL-C: high-density 
lipoprotein cholesterol, IFG: impaired fasting glucose, IGT: impaired glucose tolerance and IFG/IGT: combined impaired fasting glucose and 
impaired glucose tolerance, SBP: systolic blood pressure, TGs: triglycerides, WC: waist circumference.Page 4 of 7
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iate regression model, a combination of family history of
diabetes, increased BMI, and hypertension in men and
family history of diabetes and increased WC in women led
to the lowest calculated NNTS of 1.6 (95%CI: 1.57–1.71)
and 2.2 (95%CI: 2.1–2.4) respectively.
Discussion
In a population-based study of Iranian urban residents,
we reported prevalence of previously diagnosed and undi-
agnosed diabetes, isolated IFG, isolated IGT, and com-
bined IFG/IGT, using OGTT. We found that about one-
thirds of Tehranian adults aged ≥ 20 years were affected by
some degrees of hyperglycemia. Approximately 14% of all
participants were known to be involved with diabetes, of
whom about one-third were undiagnosed.
The reported prevalence rate of diabetes in the current
study was more than twice the rate predicted by King et al.
for the Iranians in 2000. They estimated the prevalence of
diabetes to be 5.5%, 5.7%, and 6.8% in 1995, 2000, and
2025 respectively [16]. As acknowledged, such studies are
flawed with old data and are limited by paucity of data
and assumptions required for generating the estimates
[16]. Recently the national prevalence of type 2 diabetes
among Iranian citizens, aged 25 to 64 years, has been
reported to be 7.7%; of these half had undiagnosed diabe-
tes [9]. It seems that the prevalence of diabetes and pre-
diabetes states among Iranian adults are the same as those
reported from neighbouring countries [17,18]. Similar to
our results, the prevalence of diabetes using WHO criteria
in an urban population in south India was 14.3% [19].
High prevalence of obesity and metabolic syndrome
might contribute to an increased prevalence of glucose
tolerance abnormalities in Iran [20-23]. Undiagnosed dia-
betes is reported to be as prevalent as or even more preva-
lent than diagnosed diabetes [24,25]. The proportion of
undiagnosed relative to total diabetes has been reported
to be 70% among the Danish [26], 60.6% in Indians [19]
and 47% among Australians [27]. The proportion that
was reported in the current study is in concordance with
the results from the US population [28]. Although there is
increased awareness of diabetes in our population with
improvement of education and access to medical care, but
this was not sufficient to decrease the percent of undiag-
nosed cases.
The association between diabetes and gender has been the
focus of several studies with inconsistent results [29-32].
We found that the total prevalence of type 2 diabetes was
Table 3: Risk factors associated with undiagnosed diabetes in the Tehranian adults.
Variables Men Women
Odds ratioa 95%CI Odds ratioa 95%CI
Family history of diabetes (yes) 1.7b 1.2–2.3 1.8 1.4–2.3
Blood pressure > 140/90 mmHg 2.5 1.8–3.4 1.9 1.5–2.6
BMI ≥ 25 kg/m2 4.1 2.7–6.1 2.7 1.8–4.0
Waist circumference (cm) men: >102, women: >88 2.7 1.9–3.8 2.9 2.1–4.1
Low leisure time physical activity 0.82 0.5–1.5 1.0 0.7–1.6
Triglycerides > 2.8 mmol/l 2.4 1.8–3.3 2.8 2.2–3.7
HDL-C< 0.9 mmol/l 1.1 0.8–1.4 1.6 1.3–2.1
a: Odds ratio (95% confidence interval): age-adjusted univariate logistic regression analysis.
b: all p values <0.05 except for low leisure time physical activity in both gender and HDL-C in men. BMI: body mass index, CI: confidence interval, 
HDL-C: high-density lipoprotein cholesterol.
Table 4: Number needed to screen for undiagnosed diabetes in various risk factor categories among the Tehranian adults.
Variables Men Women
NNTSa 95% CI NNTSa 95% CI
Family history of diabetes (yes) 15.6 14.0–17.7 13.7 12.5–15.1
Blood pressure ≥ 140/90 mmHg 8.3 7.7–9.1 9.3 8.7–10.1
BMI ≥ 25 kg/m2 13.5 12.1–15.1 15.5 14.1–17.3
Abdominal obesity: waist circumference (cm)>102 in men and > 88 in women 8.0 8.4–8.7 12.5 11.5–13.8
Triglycerides > 2.8 mmol/l 10.8 9.8–11.9 7.8 7.3–8.4
HDL-C< 0.9 mmol/l 19.2 17.0–22.1 17.0 15.4–19.0
a: Number needed to screen (95% confidence interval) was obtained by univariate logistic regression analysis.
BMI: body mass index, CI: confidence interval, HDL-C: high-density lipoprotein cholesterol,Page 5 of 7
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confirmed by the national survey of diabetes in Iran
(8.3% in women vs. 7.1% in men) [9] and differs from
data of the U.S [33] and Australia [27]. The higher preva-
lence of metabolic syndrome in our women population
may be the underlying cause for this sex difference
[20,21]. In the current study, IGT was more prevalent
among women, whereas IFG was observed more among
men. Data from national survey of diabetes in Iran [9] and
the U.S. [33] also showed the higher prevalence of IFG in
the male population. It was previously shown that in pop-
ulations where IFG was more prevalent in men, IGT was
identified more among women [29]. In many studies, it
was reported that the prevalence of diabetes increased
with age [29,31]. In the current study, in both genders,
prevalence of diagnosed and undiagnosed diabetes, IGT,
and IFG/IGT increased with age, whereas IFG prevalence
increased with age only in women
Undiagnosed type 2 diabetes is not milder than clinically
detected diabetes [15]. We found that cardiovascular risk
profile of subjects with undiagnosed diabetes either
equalled or was higher than that of previously diagnosed
patients. Hariss et al. in a review study reported that peo-
ple with undiagnosed diabetes have substantial rates of
risk factors for diabetes complications although they are
not as hyperglycemic as are patients with diagnosed dia-
betes [34]. Similar to other reports [35,36], most risk fac-
tors independently associated with undiagnosed diabetes
in the current study were components of the metabolic
syndrome [12], high prevalence of which were reported in
our population [20,21].
In the current study, we identified a combination of risk
factors that had the lowest NNTS in our population. The
target group for diabetes screening among men was dis-
tinct from women. Screening among men with family his-
tory of diabetes, increased BMI, and hypertension, and
among women with family history of diabetes and
abdominal obesity, is more efficient. In our multivariate
analysis, we showed that high BMI in men and high WC
in women were independent risk factors for type 2 diabe-
tes, findings that were supported by the OBESITY in ASIA
Collaboration study [37]. Like other reports [15], the cur-
rent study showed that screening for type 2 diabetes might
be more efficient among men due to lower NNTS. Our
data as that of the Rathmann et al. [15] study, showed that
hypertriglyceridemia, as a marker of insulin resistance,
had the least NNTS in women compared to men (7.8 vs.
10.8 respectively); in multivariate regression analysis
however it was excluded from our model; thus we pre-
sented a more practical model for identifying undiag-
nosed diabetes in both genders.
There are several points that should be considered when
examining the results of this study. First, given the rising
trend in the prevalence of obesity [23] and diabetes [38]
in our population, the reported figures in this study might
be an underestimation. Second, the cross-sectional study
design prevents causal inference to be made about the
relationship between risk factors and undiagnosed type 2
diabetes. The strengths of our study include using both
FPG and 2h-PG for determining of undiagnosed diabetes
and having a large sample size, representative of Tehran.
Conclusion
In conclusion, about one third of Tehranian adults had
disturbed glucose tolerance or diabetes. One- third of
total cases with diabetes were undiagnosed. Screening
individuals with BMI ≥ 25 kg/m2 (men), hypertension
(men), abdominal obesity (women) and family history of
diabetes may be more efficient; however, further evidence
is required to identify how, who, and how often people
should be screened.
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